ストックスクリーナーアプリを入手
169.04
0.32%
0.57
前日終値:
$168.47
開ける：
$168.885
24時間の取引高:
1.11M
Relative Volume:
0.20
時価総額：
$268.55B
収益：
$113.10B
当期純損益:
$16.33B
株価収益率:
17.35
EPS:
9.7425
ネットキャッシュフロー:
$10.35B
1週間 パフォーマンス:
+2.16%
1か月 パフォーマンス:
+3.05%
6か月 パフォーマンス:
+31.63%
1年 パフォーマンス:
+28.99%
1日の値動き範囲:
$168.69
$170.12
1週間の範囲:
$165.87
$170.27
52週間の値動き範囲:
$94.33
$171.77
Morgan Stanley Stock (MS) Company Profile
MS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
168.97 | 267.75B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
815.05 | 243.20B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
92.54 | 164.70B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
126.21 | 110.82B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
357.43 | 28.68B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 開始されました | BMO Capital Markets | Outperform |
| 2025-07-09 | アップグレード | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-09-11 | ダウングレード | Goldman | Buy → Neutral |
| 2024-08-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-01-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-01-17 | ダウングレード | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-11-28 | ダウングレード | Societe Generale | Buy → Hold |
| 2023-11-20 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | ダウングレード | Odeon | Buy → Hold |
| 2023-10-20 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-07 | 開始されました | HSBC Securities | Buy |
| 2023-07-12 | アップグレード | Odeon | Hold → Buy |
| 2023-01-18 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-10 | アップグレード | Odeon | Sell → Hold |
| 2023-01-04 | ダウングレード | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | ダウングレード | Odeon | Hold → Sell |
| 2022-05-03 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-01-28 | ダウングレード | Odeon | Buy → Hold |
| 2021-12-03 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 繰り返されました | Jefferies | Buy |
| 2021-09-29 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-09-28 | ダウングレード | Berenberg | Buy → Hold |
| 2021-08-13 | ダウングレード | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 再開されました | Keefe Bruyette | Outperform |
| 2021-06-09 | 開始されました | Jefferies | Buy |
| 2021-04-21 | アップグレード | Berenberg | Hold → Buy |
| 2021-03-02 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 開始されました | Daiwa Securities | Neutral |
| 2021-01-04 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-11-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-10-13 | 再開されました | JP Morgan | Overweight |
| 2020-07-08 | 開始されました | Seaport Global Securities | Buy |
| 2020-06-24 | アップグレード | DA Davidson | Neutral → Buy |
| 2020-06-23 | 繰り返されました | UBS | Buy |
| 2020-05-21 | アップグレード | Odeon | Hold → Buy |
| 2020-04-14 | アップグレード | Societe Generale | Sell → Buy |
| 2020-03-13 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-04 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-21 | ダウングレード | DA Davidson | Buy → Neutral |
| 2020-02-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-01-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 開始されました | DA Davidson | Buy |
| 2020-01-06 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-29 | ダウングレード | Odeon | Buy → Hold |
| 2019-10-10 | アップグレード | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | アップグレード | Citigroup | Neutral → Buy |
| 2019-04-18 | ダウングレード | Citigroup | Buy → Neutral |
すべてを表示
Morgan Stanley (MS) 最新ニュース
HASI price target raised to $47 from $44 at Morgan Stanley - TipRanks
TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus
Watch Morgan Stanley's Wilson Sticks to His 7,800 Call for S&P 500 - Bloomberg.com
AI Data Center Opportunities Underpin Morgan Stanley's Bullish Stance On This Stock - Investor's Business Daily
Lam Research (NASDAQ:LRCX) Price Target Raised to $158.00 at Morgan Stanley - MarketBeat
Morgan Stanley's long position in H-shares of Cosco Shipping decreases to 6.16% on Nov 27HKEX - MarketScreener
‘It’s Not Even Close,’ Says Morgan Stanley About Nvidia Stock - TipRanks
Marvell price target raised to $86 from $76 at Morgan Stanley - Yahoo Finance
Morgan Stanley Sees More Balanced Risk/Reward for Donaldson (DCI) - Insider Monkey
Atmos Energy (ATO) Gets Target Boost as Morgan Stanley Revises Utility Sector Outlook - Insider Monkey
Morgan Stanley flags emerging opportunity in this sector By Investing.com - Investing.com Canada
Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equal Weight, Adjusts PT to CA$29.41 From CA$19.64 - MarketScreener
Morgan Stanley Initiates Nova at Equalweight With $335 Price Target - MarketScreener
Morgan Stanley Downgrades Inspire Medical Systems to Equal Weight From Overweight, Adjusts PT to $130 From $105 - MarketScreener
Morgan Stanley Raises Price Target on Veracyte to $48 From $40, Keeps Underweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Tempus AI to $85 From $80, Keeps Overweight Rating - MarketScreener
Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $210 From $197, Maintains Overweight Rating - MarketScreener
Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference - Business Wire
Morgan Stanley Raises Price Target on Natera to $265 From $220, Keeps Overweight Rating - MarketScreener
Morgan Stanley Adjusts Price Target on Lam Research to $158 From $137, Maintains Equalweight Rating - MarketScreener
Morgan Stanley Raises Price Target on IQVIA Holdings to $265 From $250, Keeps Overweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Guardant Health to $130 From $105, Keeps Overweight Rating - MarketScreener
Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Adaptive Biotechnologies to $21 From $16, Keeps Equalweight Rating - MarketScreener
Morgan Stanley Upgrades DexCom to Overweight From Equalweight, Adjusts PT to $75 From $63 - MarketScreener
Procept BioRobotics price target lowered to $51 from $56 at Morgan Stanley - TipRanks
Morgan Stanley Initiates Solaris Energy Infrastructure at Overweight With $68 Price Target - MarketScreener
Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17 - MarketScreener
Amid the Bitcoin pandemonium, on leading bank says investors need to get exposure - Proactive financial news
Morgan Stanley Adjusts Price Target on Applied Materials to $273 From $252, Maintains Overweight Rating - MarketScreener
Morgan Stanley Initiates Danaher at Overweight With $270 Price Target - MarketScreener
Morgan Stanley Initiates Waters at Equalweight With $423 Price Target - MarketScreener
Morgan Stanley Initiates Mettler-Toledo International at Equalweight With $1,550 Price Target - MarketScreener
Morgan Stanley Says Mortgage Aid May Halt China’s Housing Slump - Bloomberg.com
Solaris Energy initiated with an Overweight at Morgan Stanley - TipRanks
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com India
Morgan Stanley sees mainland China property slump extending into 2026 - South China Morning Post
Scandic Hotels stock downgraded by Morgan Stanley on UK budget impact - Investing.com
Morgan Stanley initiates coverage on Solaris Energy stock with Overweight rating - Investing.com
Morgan Stanley Raises Nvidia’s Price Target, Cites Persisting Dominance amid Soaring AI Demand - kaohoon international
Morgan Stanley Bullish on Citigroup (C) - MSN
Morgan Stanley Bullish on Eli Lilly and Company (LLY) - Finviz
Morgan Stanley Bearish on Progressive Corporation (PGR) - Insider Monkey
NVIDIA Corporation (NVDA) Morgan Stanley Raises Target Forecast - The Globe and Mail
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares - GlobeNewswire Inc.
Morgan Stanley Keeps Chord Energy (CHRD) Neutral Following Q3 Results - Insider Monkey
Morgan Stanley Turns Cautious on Corebridge (CRBG) After Key Transaction - Insider Monkey
Morgan Stanley Sees Industry Cycle Shifts, Cuts Jackson Financial (JXN) Price Target - Insider Monkey
Morgan Stanley’s Confidence Rises in American Healthcare REIT (AHR) Following Senior Housing Review - Insider Monkey
DT Midstream (DTM) Price Target Increased by Morgan Stanley After “Relatively In-Line” Q3 Earnings - Insider Monkey
Bank Of America Opens The Door To Crypto, Joining Morgan Stanley And BlackRock - Stocktwits
Morgan Stanley (MS) 財務データ
収益
当期純利益
現金流量
EPS
0.51%
0.14%
大文字化:
|
ボリューム (24 時間):